Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm study
Background No consensus exists on the right way to scale back oral corticosteroids after the initiation of biologics in extreme ...
